186 related articles for article (PubMed ID: 15639052)
1. Developments in glucocorticoid therapy.
Bijlsma JW; Saag KG; Buttgereit F; da Silva JA
Rheum Dis Clin North Am; 2005 Feb; 31(1):1-17, vii. PubMed ID: 15639052
[TBL] [Abstract][Full Text] [Related]
2. [Benefits and risks of glucocorticoid therapy for the treatment of rheumatoid arthritis and management of glucocorticoid-induced osteoporosis].
Suzuki Y; Wakabayashi T; Saito E; Yamada C; Suwa A
Clin Calcium; 2009 Mar; 19(3):404-15. PubMed ID: 19252251
[TBL] [Abstract][Full Text] [Related]
3. Glucocorticoids: action and new therapeutic insights in rheumatoid arthritis.
Kirwan J; Power L
Curr Opin Rheumatol; 2007 May; 19(3):233-7. PubMed ID: 17414948
[TBL] [Abstract][Full Text] [Related]
4. Pharmacology of glucocorticoids in rheumatoid arthritis.
Spies CM; Bijlsma JW; Burmester GR; Buttgereit F
Curr Opin Pharmacol; 2010 Jun; 10(3):302-7. PubMed ID: 20202903
[TBL] [Abstract][Full Text] [Related]
5. [Glucocorticoids in rheumatic diseases - what is the optimal dose?].
Krause D
Dtsch Med Wochenschr; 2012 Sep; 137(36):1751-4. PubMed ID: 22933199
[TBL] [Abstract][Full Text] [Related]
6. EULAR evidence-based and consensus-based recommendations on the management of medium to high-dose glucocorticoid therapy in rheumatic diseases.
Duru N; van der Goes MC; Jacobs JW; Andrews T; Boers M; Buttgereit F; Caeyers N; Cutolo M; Halliday S; Da Silva JA; Kirwan JR; Ray D; Rovensky J; Severijns G; Westhovens R; Bijlsma JW
Ann Rheum Dis; 2013 Dec; 72(12):1905-13. PubMed ID: 23873876
[TBL] [Abstract][Full Text] [Related]
7. Effects of glucocorticoids on inflammation and arthritis.
Morand EF
Curr Opin Rheumatol; 2007 May; 19(3):302-7. PubMed ID: 17414960
[TBL] [Abstract][Full Text] [Related]
8. Novel insights into mechanisms of glucocorticoid action and the development of new glucocorticoid receptor ligands.
Löwenberg M; Stahn C; Hommes DW; Buttgereit F
Steroids; 2008 Oct; 73(9-10):1025-9. PubMed ID: 18221974
[TBL] [Abstract][Full Text] [Related]
9. The epidemiology of glucocorticoid-associated adverse events.
McDonough AK; Curtis JR; Saag KG
Curr Opin Rheumatol; 2008 Mar; 20(2):131-7. PubMed ID: 18349741
[TBL] [Abstract][Full Text] [Related]
10. [New developments in glucocorticoid therapy: selective glucocorticoid receptor agonists, nitrosteroids and liposomal glucocorticoids].
Huisman AM; Jacobs JW; Buttgereit F; Bijlsma JW
Ned Tijdschr Geneeskd; 2006 Mar; 150(9):476-80. PubMed ID: 16553045
[TBL] [Abstract][Full Text] [Related]
11. [Frequency of side effects of glucocorticoid therapy in relation to the regimen for administering the hormonal preparations].
Zaremba EF
Vrach Delo; 1984 Nov; (11):60-3. PubMed ID: 6396947
[No Abstract] [Full Text] [Related]
12. [New developments in glucocorticoid therapy: selective glucocorticoid receptor agonists, nitrosteroids and liposomal glucocorticoids].
Spijker AJ
Ned Tijdschr Geneeskd; 2006 May; 150(21):1205; author reply 1205. PubMed ID: 16768287
[No Abstract] [Full Text] [Related]
13. Problems related to systemic glucocorticoid therapy in children.
Melo-Gomes JA
J Rheumatol Suppl; 1993 Apr; 37():35-9. PubMed ID: 8501750
[TBL] [Abstract][Full Text] [Related]
14. Revisiting the toxicity of low-dose glucocorticoids: risks and fears.
Da Silva JA; Jacobs JW; Bijlsma JW
Ann N Y Acad Sci; 2006 Jun; 1069():275-88. PubMed ID: 16855155
[TBL] [Abstract][Full Text] [Related]
15. Glucocorticoid therapy-induced skin atrophy.
Schoepe S; Schäcke H; May E; Asadullah K
Exp Dermatol; 2006 Jun; 15(6):406-20. PubMed ID: 16689857
[TBL] [Abstract][Full Text] [Related]
16. Steroids in rheumatic disease: a podiatric perspective.
Roth RD
Clin Podiatr Med Surg; 1988 Jan; 5(1):135-54. PubMed ID: 2962716
[TBL] [Abstract][Full Text] [Related]
17. Effects of glucocorticoid treatment on focal and systemic bone loss in rheumatoid arthritis.
Di Munno O; Delle Sedie A
J Endocrinol Invest; 2008 Jul; 31(7 Suppl):43-7. PubMed ID: 18791351
[TBL] [Abstract][Full Text] [Related]
18. Glucocorticoids and their actions in cells.
Cidlowski JA
Retina; 2009 Jun; 29(6 Suppl):S21-3. PubMed ID: 19553792
[TBL] [Abstract][Full Text] [Related]
19. New glucocorticoids on the horizon: repress, don't activate!
Song IH; Gold R; Straub RH; Burmester GR; Buttgereit F
J Rheumatol; 2005 Jul; 32(7):1199-1207. PubMed ID: 16041872
[TBL] [Abstract][Full Text] [Related]
20. Novel insights into glucocorticoid-mediated diabetogenic effects: towards expansion of therapeutic options?
van Raalte DH; Ouwens DM; Diamant M
Eur J Clin Invest; 2009 Feb; 39(2):81-93. PubMed ID: 19200161
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
